Our study raises the possibility that LBP exerts its effects not only by targeting SIRT1 but also by targeting ATF6, which will further ameliorate the UPR and ER stress and may represent a therapeutic strategy for obesity. The gene discussed is ATF6; the disease is obesity due to melanocortin 4 receptor deficiency.